Dennis Peters

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Locally Advanced

Radiation Induced

Muscle Invasive Bladder Cancer

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort, Dennis Peters, Erik Hooijberg, Annegien Broeks, Charlotte L Zuur, Bas W G van Rhijn, Daniel J Vis, Michiel S Van Der Heijden, Lodewyk F A Wessels
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature communications 15 (1) (2024)
Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort, Dennis Peters, Erik Hooijberg, Annegien Broeks, Charlotte L Zuur, Bas W G van Rhijn, Daniel J Vis, Michiel S Van Der Heijden, Lodewyk F A Wessels
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature communications 15 (1) (2024)
Maksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe, Iris M Seignette, Jan-Jaap J Mellema, Maartje Alkemade, Alberto Gil-Jimenez, Dennis Peters, Wim Brugman, Chantal F Stockem, Erik Hooijberg, Annegien Broeks, Bas W G van Rhijn, Laura S Mertens, Antoine G Van der Heijden, Niven Mehra, Maurits L van Montfoort, Lodewyk F A Wessels, Daniel J Vis, Michiel S Van Der Heijden
Platinum-based chemotherapy induces opposing effects on immunotherapy response-related spatial and stromal biomarkers in the bladder cancer microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort, Dennis Peters, Erik Hooijberg, Annegien Broeks, Charlotte L Zuur, Bas W G van Rhijn, Daniel J Vis, Michiel S Van Der Heijden, Lodewyk F A Wessels
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature communications 15 (1) (2024)
Hielke Martijn de Vries, Tynisha S Rafael, Alberto Gil-Jimenez, Jeantine M de Feijter, Elise Bekers, Elsbeth van der Laan, Marta Lopez-Yurda, Erik Hooijberg, Annegien Broeks, Dennis Peters, Iris M Seignette, Floris J Pos, Simon Horenblas, Bas W G van Rhijn, Ekaterina S Jordanova, Oscar R Brouwer, Eva Schaake, Michiel S Van Der Heijden
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, Sjoerd Klarenbeek, Mark Opdam, Yuval Malka, Liesbeth Hoekman, Dinja T Kruger, Onno B Bleijerveld, Chiara S Brambillasca, Justin Sprengers, Bjorn Siteur, Stefano Annunziato, Matthijs J van Haren, Nathaniel I Martin, Marieke van de Ven, Dennis Peters, Reuven Agami, Sabine C Linn, Epie Boven, A F Maarten Altelaar, Jos Jonkers, Daniel Zingg, Lodewyk F A Wessels
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. The Journal of experimental medicine 220 (11) (2023)
Hanne Lefrère, Kat S Moore, Giuseppe Floris, Joyce Sanders, Iris M Seignette, Tycho Bismeijer, Dennis Peters, Annegien Broeks, Erik Hooijberg, Kristel Van Calsteren, Patrick Neven, Ellen Warner, Fedro Alessandro Peccatori, Sibylle Loibl, Charlotte Maggen, Sileny N Han, Katarzyna Joanna Jerzak, Daniela Annibali, Diether Lambrechts, Karin E de Visser, Lodewyk F A Wessels, Liesbeth Lenaerts, Frédéric Amant
Poor outcome in postpartum breast cancer patients is associated with distinct molecular and immunological features. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karlijn Hummelink, Vincent van den Noort, Mirte Muller, Robert D Schouten, Ferry Lalezari, Dennis Peters, Willemijn S M E Theelen, Viktor Hendrik Koelzer, Kirsten D Mertz, Alfred Zippelius, Michel van den Heuvel, Annegien Broeks, John B A G Haanen, Ton N M Schumacher, Gerrit A Meijer, Egbert F Smit, Kim Monkhorst, Daniela S Thommen
PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)